A synergistic partnership between IL-33/ST2 and Wnt pathway through Bcl-xL drives gastric cancer stemness and metastasis

• Published in: Oncogene 2023-02, Vol.42 (7), p.501-515
• Main Authors: Kwon, Jong-Wan, Seok, Sang-Hyuk, Kim, Somi, An, Hyeok-Won, Choudhury, Anahita Dev, Woo, Sang-Ho, Oh, Jeong-Seop, Kim, Jong Kyoung, Voon, Dominic C., Kim, Dae-Yong, Park, Jun Won
• Format: Article
• Language: English
• Subjects: 13; 14; 38; 38/44; 38/61; 38/70; 38/77; 42; 42/100; 42/35; 45; 631/532/2441; 631/67/1504/1829; 64; 64/60; Apoptosis; Bcl-x protein; Carcinogenesis; Carcinogenesis - genetics; Cell Biology; Cell Line, Tumor; Cell self-renewal; Chemoresistance; Gastric cancer; Human Genetics; Humans; Interleukin-1 Receptor-Like 1 Protein - genetics; Interleukin-1 Receptor-Like 1 Protein - metabolism; Interleukin-33 - genetics; Interleukin-33 - metabolism; Internal Medicine; MAP kinase; Medicine; Medicine & Public Health; Metastases; Metastasis; Neoplastic Stem Cells - pathology; Oncology; Organoids; Stem cells; Stomach Neoplasms - pathology; Tumorigenesis; Tumorigenicity; Wnt protein; Wnt Signaling Pathway
• ISSN: 0950-9232; 1476-5594
• DOI: 10.1038/s41388-022-02575-5

ST2 functions as a receptor for the cytokine IL-33. It has been implicated in carcinogenesis. In this study, we sought to mechanistically determine how ST2 and IL-33 function to support cancer stem cell (CSC) activity and drive gastric cancer (GC) pathogenesis. ST2+ subpopulation spontaneously arose during gastric tumorigenesis. A thorough evaluation of ST2 and IL-33 expression in gastric tumors revealed that they show an overlapping expression pattern, notably in poor differentiated GC and metastasis foci. Moreover, their expression levels are clinically correlated to cancer progression. Using a genetic model of CSC-driven gastric carcinogenesis, ST2+ subpopulation displays increased tumorigenicity, chemoresistance and metastatic potentials through increased survival fitness endowed by an elevated MAPK-regulated Bcl-xL. The IL-33/ST2 axis enhances the self-renewal and survival of GC stem cells and organoids. Importantly, we observed a synergistic cooperation between IL-33/ST2 and the canonical Wnt pathway in transactivating Wnt-dependent transcription and supporting CSC activity, a partnership that was abrogated by inhibiting Bcl-xL. Concordant with this, ST2+ subpopulation was targeted by MEK1/2 and Bcl-xL-specific inhibitors. These findings establish ST2 as a functional CSC marker that fortifies the Wnt signal while availing a novel therapeutic strategy to suppress GC progression by targeting the IL-33/ST2/Bcl-xL signaling axis.